Internal Funding Sources for the College of Medicine

 
PROGRAM NAME
RSNA (Radiological Society of North America) Medical Student Departmental Award
OBJECTIVES
To enable Departments of Diagnostic Radiology to provide research opportunities to medical students
AWARD
$2,000 per month for a program of 3 months
CONDITIONS
Final report of project research
ELIGIBILITY
Third or fourth year medical students
DEADLINE
June 1
NOTIFICATION OF ACTION
July 1
HOW TO APPLY
Contact Dr. Kevin Berbaum, 3170 Medical Laboratories, (5-8122)
ADDITIONAL INFORMATION
Kevin Berbaum, 3170 ML, 5-8122
  
PROGRAM NAME
Pilot and Feasibility Grants
OBJECTIVES
Promote studies at cellular level in diabetes and/or mechanisms of hormone action
AWARD
$10,000-$20,000 for up to two years
CONDITIONS
No duplicate funding
ELIGIBILITY
Tenure-track faculty
DEADLINE
April 15
NOTIFICATION OF ACTION
July
HOW TO APPLY
Contact person below
ADDITIONAL INFORMATION
Chris Werling, 3E-19 VA, 339-7147
  
PROGRAM NAME
ESR Facility Seed Activity
OBJECTIVES
Support new research directions by assisting in gathering of data the will enhance competitiveness for external funding
AWARD
Pilot experiments only; facility user fees waived
CONDITIONS
Investigator supports supply costs
ELIGIBILITY
Students, tenure-track faculty, research scientists
DEADLINE
None
NOTIFICATION OF ACTION
N/A
HOW TO APPLY
Contact ESR Facility
ADDITIONAL INFORMATION
Garry Buettner, 68 EMRB, 5-6749
^ top ^
  
PROGRAM NAME
Residency Research Program
OBJECTIVES
Train otolaryngology residents in medical research
AWARD
Up to $2,500
CONDITIONS
Must be approved by Departmental Research Committee
ELIGIBILITY
Must be Otolaryngology resident
DEADLINE
Plan submitted during R2 year
NOTIFICATION OF ACTION
Approved during R2 year
HOW TO APPLY
Contact person below
ADDITIONAL INFORMATION
Richard Tyler, Chair, Otolaryngology Research Committee, C21-6 GH, 6-2471
  
PROGRAM NAME
Gastroenterology-Hepatology Training Program
OBJECTIVES
Prepare MDs and Ph.D.s for investigation of diseases relevant to the digestive system
AWARD
Salary and limited supply and travel budgets
CONDITIONS
N/A
ELIGIBILITY
Must be permanent U.S. resident who has obtained MD or Ph.D. degree
DEADLINE
Variable
NOTIFICATION OF ACTION
Variable, depending on deadline
HOW TO APPLY
Obtain application materials from contact person below
ADDITIONAL INFORMATION
Joel Weinstock, Internal Medicine, Division of Gastroenterology-Hepatology, 4607 JCP, 6-3792
  
PROGRAM NAME
 Carver Medical Research Initiative Grants
OBJECTIVES
Funding for faculty who have novel research ideas with long-range potential but need to gather preliminary data before submitting an external proposal.
AWARD
Up to $30,000
CONDITIONS
None Specified
ELIGIBILITY
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
DEADLINE
December 1
NOTIFICATION OF ACTION
February 1
HOW TO APPLY
ADDITIONAL INFORMATION
Angie Robertson, CCOM Research Administrator
  
PROGRAM NAME
 Carver Trust Foundation Collaborative Pilot Grants
OBJECTIVES
Seed funding for novel pilot collaborative research to allow PI's to gather preliminary data to submit an external grant.
AWARD
Up to $50,000
CONDITIONS
None Specified
ELIGIBILITY
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
DEADLINE
December 1
NOTIFICATION OF ACTION
February 1
HOW TO APPLY
ADDITIONAL INFORMATION
Angie Robertson, CCOM Research Administrator
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - Aiming For A Cure Foundation Grant Opportunity
OBJECTIVES
The Aiming For A Cure (AFAC) Foundation supports cancer research with a special interest in, but not limited to, childhood cancers. The maximum award limit will be $60,000. Any faculty or staff member at the University of Iowa is eligible to apply. The project to be supported will be selected by a peer-review process of all applications submitted to the AFAC Scientific Advisory Board
AWARD
$60,000 Maximum
CONDITIONS
Deviations over the page limit will be automatically rejected.
ELIGIBILITY
The principal investigator must have a full time affiliation with the University and will conduct the research project on the UI campus. Non faculty investigators must have a letter of support from a UI faculty sponsor. of Iowa
DEADLINE
Noon, Wednesday, January 14, 2011.  Submit to:  Tami Thompson, Holden Comprehensive Cancer Center.  Please send an electronic copy and one original.
NOTIFICATION OF ACTION
Notification of award will be made around March 1, 2011.
HOW TO APPLY
Guidelines available on Holden website, www.uihealthcare.org/otherservices.aspx?id=21046 Comprehensive Cancer Center
ADDITIONAL INFORMATION
Contact: David Tatman (Pediatric BMT Program or 356-4324)
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - Seed Grants - American Cancer Society
OBJECTIVES
For junior faculty members a one-year, cancer-focused research award supported through the Holden Comprehensive Cancer Center's American Cancer Society Institutional Research Grant. The purpose of these seed grant awards is to foster research in cancer that cannot readily be supported through other available sources, and to permit the initiation of promising new projects or novel ideas necessary to obtain the preliminary results for junior faculty to successfully compete for national research grants.
AWARD
Up to $30,000 per award
CONDITIONS
Applicants are not eligible if they have grant support from a national agency, have previously served as P.I. on peer-reviewed grants from a national agency (even if such funding has expired), or if they have received prior support from the American Cancer Society. Recipients must submit a progress report, summarizing the results of the study supported by the ACS-IRG, with information on published papers and grant support as a result of, and separately from, the seed grant support received for the project, and copies of all publications resulting from the work. Annual updates will be required for five years.
ELIGIBILITY
Applications are accepted from junior faculty in all departments and Colleges at the University of Iowa. Applicants should be within six years of their first independent research or faculty appointment. Applications are encouraged from investigators performing basic or clinical research including cancer control, health services research, and behavioral/psychosocial research, and health policy and outcomes research related to cancer. ACS funds are intended to assist independent researchers in conducting initial explorations which may lead to publication(s) and a successful application for support from a national funding agency. These awards are NOT intended to provide bridge or other funding for more experienced investigators. Applicants must have completed training and be eligible to apply as principal investigator for grant support from a national agency, but not have any competitive grant at the time of application.
DEADLINE
Noon, Monday, February 25, 2013
NOTIFICATION
Notification of awards will be made in March, 2013
HOW TO APPLY
The guidelines and forms may be downloaded from: www.uihealthcare.org/otherservices.aspx?id=21046
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC), please see http://www.uihealthcare.org/HoldenComprehensiveCancerCenter/.
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - Vere D. Wenger Travel Award
OBJECTIVES
Vere Wenger funds are avaiable to support partial travel expenses of faculty and staff members in all fields (humanities, law, medicine, natural and social sciences, etc.) from all colleges at the University of Iowa who present papers at conferences and/or who attend professional meetings which contribute to the knowledge of cancer or for the well-being of cancer patients.
AWARD
Awards up to $750 for only one fiscal year, if the applicant has no other grant or departmental funding available.
CONDITIONS
Awards made only in cases where other sources of funding unavailable or inadequate; research must contribute to knowledge of cancer or deal with ways to increase the well-being of cancer patients. Decisions concerning use of funds are made by the leaders of the six formal research programs of the HCCC.
ELIGIBILITY
All University of Iowa faculty and staff
DEADLINE
Open
NOTIFICATION OF ACTION
Requests are considered upon receipt of application and as funds remain available. Notification usually within one month of request.
HOW TO APPLY
Inquries from HCCC members and others should be made to the program leader most appropriate for the research being supported
http://www.uihealthcare.org/otherservices.aspx?id=21023
1) Letter defining details of dates, location and sponsor of meeting.
2) Letter of acceptance of the paper or a program listing the presentation
3) Brief (2 paragraph) explanation of how the paper relates to cancer or cancer patients
4) Abstract of the paper
5) Endorsement by Leader of Holden Cancer Center Research Program.
ADDITIONAL INFORMATION
Tami Thompson, Cancer Center Administration, 5970Z JPP, 353-8987
  
PROGRAM NAME
OBJECTIVES
The Holden Comprehensive Cancer Center will award two prizes from the Donald D. Dorfman Endowment for the best research papers in leukemia and lymphoma published in 2011 or 2012. One award will be to an investigator in the area of basic laboratory research and one to an investigator in the area of clinical research, including population science.
AWARD
This award is granted every other year through the Holden Comprehensive Cancer Center. The amount of each award is $2,500. A plaque will be presented to the recipients at a recognition event with members of the Dorfman family present.
CONDITIONS
Awards will be granted to one basic and one clinical research publication. Eligible papers are to be published in peer-reviewed journals in 2011 or 2012, or accepted for publication and currently in press.
ELIGIBILITY
Recipients must be members of the Holden Comprehensive Cancer Center. Applicants may submit more than one paper, but each paper will be reviewed individually. Recipients of the Dorfman Award within the past two years are not eligible.
DEADLINE
Deadline for submission of published papers: Noon, Wednesday, September 5, 2012.
NOTIFICATION OF ACTION
Applicants will be notified of the award by October 2012, with a Recognition Event and presentation of Award Plaque to be scheduled later in 2012.
HOW TO APPLY
Applicants should submit a Cover Letter, which identifies the contact person and gives a brief summary describing why they feel the paper is deserving of the award. The summary should include the key issues addressed in the manuscript and a description of the impact of your paper on these issues. Failure to provide the summary and identify key issues will negatively impact review of the manuscript. Please forward the Cover Letter and the paper or manuscript as a signle PDF document to: Tami Thompson.
ADDITIONAL INFORMATION
 
Contact: Holden Comprehensive Cancer Center Administration
319-353-8620 Tel
www.uihealthcare.org/otherservices.aspx?id=21046
 
PROGRAM NAME
OBJECTIVES
The Holden Comprehensive Cancer Center (HCCC) seeks applications from its Cancer Center members to support development of novel clinical cancer research projects. The intent of this process is to assist investigators in the design and initiation of innovative clinical cancer studies that have a high likelihood of leading to external peer-reviewed funding, and to establish ongoing collaborations between laboratory-based programs and clinical investigators likely to result in additional research projects. Clinical research is defined as research involving human subjects, preferably in diagnostic or therapeutic cancer trials. Applications focused on development of clinical trials related to cancer prevention and quality of life in cancer survivors are also encouraged. Studies that are strictly correlative in nature, such as involving tumor samples or genomic information, will be considered only if they are designed to lead to a clinical trial for step II of this award program.
AWARD

1)  Project Development Step (Up to $10,000 seed funding)

  • Access to Cancer Center resources to assist in trial development
  • Assistance in recruitment of an adequate clinical team to conduct the trial
  • Assistance in interfacing with the University of Iowa's General Clinical Research Center as appropriate

 

2)  Clinical Trial Step

  • When pre-clinical work of Step 1 has been completed, the P.I. will submit a report to HCCC Executive Committee that outlines this progress and includes a copy of both the clinical protocol and approval documents. If all issues have been addressed adequately, the HCCC will support conduct of the clinical trial by supplying the investigators with the following:
    • Access to data management and protocol management support through the HCCC clinical trials support core, and ongoing biostatistics consultation, to support the proposed clinical trial, at no charge.
    • Up to $20,000 for other expenses including correlative studies (needs to be justified by the P.I.).
CONDITIONS
Proposals will be reviewed by the Holden Comprehensive Cancer Center's Research Review Committee and Cancer Center Executive Committee, and evaluated based on the following criteria:
Standard NIH criteria (Significance, Innovation, Approach, Investigator).
Likelihood of preliminary results leading to external peer-reviewed support.
Availability of resources in the HCCC needed to support proposed studies including clinical trial.
The fit of the trial within the portfolio of clinical trials in the Cancer Center.
ELIGIBILITY
Both junior and senior-level faculty members are eligible for these awards. The P.I. must be a full member of the Holden Comprehensive Cancer Center. Basic and clinical scientists are both eligible to apply.
DEADLINE
Noon, Wednesday, September 23, 2009.
NOTIFICATION OF ACTION
Notification of awards will be made in November 2009.
HOW TO APPLY
 
 
Project Development Step
 
All interested applicants will submit 1) Cover Letter, 2) Title cover page, 3)an NIH abstract page, 4) a single page budget, 5) a standard NIH biographical sketch of the Principal Investigator and Co-investigators, and 3) a maximum of three pages of narrative summarizing the proposed research. The narrative should include:
1)  Background and preliminary date
2)  Outline of proposed research (detailed methods are NOT needed) including a very brief description of the clinical trial that will be proposed
3)  Time line including steps needed before research can advance to a clinical trial (e.g. need for an IND, collaboration with pharmaceutical company, identification of additional collaborators)
4)  Opportunities for external peer-reviewed funding should studies prove to be successful.
ADDITIONAL INFORMATION
Contact: Cancer Center Administration (Jan 3-8634 or Tami Thompson 3-8987) for related questions.  Full guidelines can be found at
www.uihealthcare.org/otherservices.aspx?id=21046
  
PROGRAM NAME
Institutional Research Fellowship for Kidney Disease, Hypertension, and Cell Biology
OBJECTIVES
To support postdoctoral fellows or potential postdoctoral fellows whose research projects relate to one or more of these areas: kidney disease, hypertension, cell biology.
AWARD
None Specified
CONDITIONS
None Specified
ELIGIBILITY
Applicants must be a U.S. citizen or Green Card holder, have received an M.D. or Ph.D. degree (or equivalent), and may not have received more than three years of support from a National Research Service Award.
DEADLINE
 
NOTIFICATION OF ACTION
None Specified
HOW TO APPLY
Candidates interested in applying for this award are invited to inquire at the Nephrology Division office (356-3446).
ADDITIONAL INFORMATION
None Specified
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - SPORE Career Development Project
OBJECTIVES
The Holden Comprehensive Cancer Center, in conjunction with the Mayo Clinic, holds a National Cancer Institute Specialized Program of Research Excellence (SPORE) grant for lymphoma research. Associated with this grant is a Career Development Program, aimed toward basic scientists who are interested in developing a translational research focus or clinicians wishing to acquire the laboratory skills required to become translational researchers in lymphoma.
AWARD
A maximum of $23,405 per year in direct costs will be provided through the Iowa/Mayo SPORE grant with $23,405 provided in matching institutional support from each institution for a total award of $46,810.  The exact amount of the award is contingent on NIH funding.
CONDITIONS
None Specified
ELIGIBILITY
Two types of individuals targeted are:
-- Laboratory investigators at the senior post-doctoral or junior faculty level (Assistant Professor or Research Scientist) who have demonstrated outstanding research potential and have an interest in a career in translational lymphoma research, but are not yet independently funded to perform this research. More experienced successful investigators with an interest in shifting their focus towards translational lymphoma research, are also eligible.
-- Clinicians who have demonstrated interest and ability in translational research during their clinical fellowship training, are committed to careers in translational research, and wish to devote the first two years of their faculty careers to additional research training in pursuit of this career.
DEADLINE
The deadline for application submission is noon, Monday, June 3, 2013.
NOTIFICATION OF ACTION
None Specified
HOW TO APPLY
The guidelines and forms may be downloaded from: http://www.uihealthcare.org/otherservices.aspx?id=21046
 
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620.For information on the Holden Comprehensive Cancer Center (HCCC), please see http://www.uihealthcare.org/otherservices.aspx?id=21046.
PROGRAM NAME
 Holden Comprehensive Cancer Center - SPORE Developmental Research Projects
OBJECTIVES
The University of Iowa / Mayo Clinic Lymphoma Specialized Program of Research Excellence (UI/MC Lymphoma SPORE) is a center grant funded through the National Cancer Institute. The mission of the UI/MC Lymphoma SPORE developmental research programs is to encourage innovative laboratory and clinical studies in lymphoma research, and to provide funds to support previously untested hypotheses or other innovative research objectives that address problems in lymphoma.  The project duration is one year.
AWARD
A maximum of $23,405 per year will be provided through the SPORE grant with $23,405 provided in Institutional support from each institution for a total award of $46,810. No overhead expenses will be paid to the applicant organization and the purchase of equipment is not allowed. All budgetary requests must be justified.
CONDITIONS
Should the investigator discontinue the project, or leave the designated institution, the UI/MC Lymphoma SPORE must be notified two months in advance of these changes. Failure to comply with this policy may jeopardize any future awards to the institution(s). The investigator may apply for transfer of the grant. If the transfer is not approved, unexpended portions of the grant must be returned to the UI/MC Lymphoma SPORE within sixty days.
ELIGIBILITY
Investigators planning to conduct their research in universities, hospitals, research institutions, and federal agencies are eligible to apply. Applicants must hold either a Ph.D. or M.D. degree or equivalent.
DEADLINE
Letter of Concept due Noon on Friday, May 24, 2013. Invited Full Proposals are due Noon on Friday, June 14, 2013.
NOTIFICATION OF ACTION
July 2013
HOW TO APPLY

Step 1: Letter-of-Concept.
The application process is initiated by the submission of a letter-of-concept describing the proposed research in addition to a statement outlining the potential of the research for improving the detection, diagnosis or treatment of lymphoma. Letters-of-concept for a Developmental Research application will be reviewed by the Developmental Research Committee of the UI/MC Lymphoma SPORE. Letters of concept are due Noon, Friday, May 24, 2013.

Step 2:Full Application.
A full application will be requested from individuals with meritorious letters of concept that meet program goals. The narrative of full applications will be limited to eight pages and should follow the NIH guidelines found in PHS 398 for R01 submissions. Invited Full Proposals are due Noon, Friday, June 14, 2013.

The guidelines and forms may be downloaded from: http://www.uihealthcare.org/otherservices.aspx?id=21046
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620.For information on the Holden Comprehensive Cancer Center (HCCC), please see http://www.uihealthcare.org/otherservices.aspx?id=21046.
  
PROGRAM NAME
OBJECTIVES
Diana Benz Seed Grant Opportunity for Support of cancer research seed grant geared towards psychosocial issues, complementary and alternative medicine, and other aspects of cancer research with a focus on quality of life for cancer patients and survivors.
AWARD
Up to $20,000 per award
CONDITIONS
The principal investigator must have a full-time affiliation with the University of Iowa and should intend to carry out the research project on campus.
ELIGIBILITY
Any faculty or staff member at the University of Iowa is eligible.
DEADLINE
Noon, February 28, 2007
NOTIFICATION OF ACTION
Award will be selected by a peer-review process of all submitted applications through the Holden Comprehensive Cancer Center.  Awards will be made in April, 2007, and effective May, 2007.
HOW TO APPLY
Contact Cancer Center Administration, 5970Z JPP, 353-8620 or download the guidelines from: www.uihealthcare.org/otherservices.aspx?id=21046
ADDITIONAL INFORMATION
  
PROGRAM NAME
Holden Comprehensive Cancer Center - Breast Cancer Research Group (BCRG) Grant Opportunity
OBJECTIVES
The Holden Comprehensive Cancer Center is announcing a competitive application process for proposals focused on breast cancer.  The awards will be made for basic, clinical and population-based research on any topic related to breast cancer.  Collaborative and translational projects are highly encouraged.
AWARD
$30,000
ELIGIBILITY
All faculty including research scientists.
GRANT TERM 1/1/2013 - 12/31/2014
DEADLINE
Monday, December 17, 2012.
NOTIFICATION OF ACTION
Notification of award will be made in December 2012.
HOW TO APPLY
Guidelines available on Holden Comprehensive Cancer Center website, http://www.uihealthcare.org/otherservices.aspx?id=21046.
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620.  For more information on the Holden Comprehensive Center (HCCC), please see www.uihealthcare.org/otherservices.aspx?id=21046